Skyhawk Therapeutics, focused on the discovery and development of small molecule therapeutics that correct RNA expression, has announced the close of $8 million in seed funding led by major family and biotech investors.
The transcriptome gives a fuller picture of how genes are expressed. RNA sequencing allows for more detailed information on cellular pathways and expression levels in cancer studies.
Researchers have released a software called Scikit-Ribo that can help biologists more accurately determine how much protein a given cell is making.
“The Disconnect Between the ‘Promise’ and the ‘Actual Impact’ is the Biggest Challenge in -Omics Based Technologies” – Zisis Kozlakidis
We’ve sat down with Dr Zisis Kozlakidis before his talk ‘Tracking Viruses in Space and Time’ at the Festival of Genomics in London 2018, were we talk virus.
Scientists have made a significant breakthrough in understanding how the molecular machines that produce key proteins in the power packs of cells are cleaned and maintained.
Microsoft thinks that artificial intelligence might be one way to fine-tune CRISPR, and resolve what scientists have been working on for a long while.
Researchers have identified a new drug target for treating Huntington’s disease, a fatal neurological disorder for which there currently is no cure or preventative therapy.
Newly described stretches of super-silenced DNA reveal a fresh approach to reprogram cell identity to use in regenerative medicine studies and one day in the clinic.
Targeted RNA sequencing is being hailed as a major growth area up to 2024. It is hotly expected that new RNAseq applications will be developed by the growing next-generation sequencing users community.
Biotech, Moderna Therapeutics has experienced scrutiny this year, but they are ready to prove why their drugs are safe for long term use.